The REDEFINE 1 and 2 trials evaluated the effects of cagrilintide 2.4 mg and semaglutide 2.4 mg on weight loss in patients with overweight or obesity, with and without type 2 diabetes
Onceweekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, doubleblind, placebocontrolled and activecontrolled, dosefinding phase 2 trial
As your skin produces more collagen fibers, the texture improves, wrinkles soften, and your complexion looks more youthful
Patients who are pregnant, nursing, under 18, or have active malignancies shouldn't use this combination
We therefore adopted an investigative approach aimed at identifying individual genes, rather than entire processes, commonly modulated in the four cell lines